Exploring market-approved azoles as potential breast cancer therapeutics targeting the VEGFR-2 biotarget

Asmaa M. Atta; Mohamed S. Nafie; Haya S. Ali; Hesham Saleh; Mohamed A. Roshdy; Mariam M. Mahmoud; E. Eid; Marwa A. Ahmed; Mario Gerges; A. M. Ghoneim; Ayman Refaie; Eman Zekry Attia; Mardi M. Algandaby; Khaled M. Darwish

doi:10.1038/s41598-025-29322-6

Affiliated Institutions

Related Publications

Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti–Epidermal Growth Factor Receptor Drugs in Human Cancer Cells

Roberto Bianco , Roberta Rosa , Vincenzo Damiano +11 more

Abstract Purpose: The resistance to selective EGFR inhibitors involves the activation of alternative signaling pathways, and Akt activation and VEGF induction have been describe...

2008 Clinical Cancer Research 143 citations

Progress and challenges towards targeted delivery of cancer therapeutics

Daniel Rosenblum , Nitin Joshi , Wei Tao +2 more

Targeted delivery approaches for cancer therapeutics have shown a steep rise over the past few decades. However, compared to the plethora of successful pre-clinical studies, onl...

2018 Nature Communications 2018 citations

Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis.

Carmen Stanca Melincovici , Adina Bianca Boşca , Sergiu Șușman +6 more

Vascular endothelial growth factor (VEGF) represents a growth factor with important pro-angiogenic activity, having a mitogenic and an anti-apoptotic effect on endothelial cells...

2018 PubMed 1160 citations

VEGF as a Therapeutic Target in Cancer

Napoleone Ferrara

Tumors require nutrients and oxygen in order to grow, and new blood vessels, formed by the process of angiogenesis, provide these substrates. The key mediator of angiogenesis is...

2005 Oncology 568 citations

Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental Hyperinflammation

Marco Cardone , Masahide Yano , Amy S. Rosenberg +1 more

The first case of human transmission of SARS-CoV-2 was reported in China in December 2019. A few months later, this viral infection had spread worldwide and became a pandemic. T...

2020 Frontiers in Immunology 52 citations

Publication Info

Year: 2025
Type: article
Volume: 15
Issue: 1
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Exploring market-approved azoles as potential breast cancer therapeutics targeting the VEGFR-2 biotarget

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                
                                    Asmaa M. Atta, 
                                
                                    Mohamed S. Nafie, 
                                
                                    Haya S. Ali
                                
                                et al.
                            
                            (2025). 
                            Exploring market-approved azoles as potential breast cancer therapeutics targeting the VEGFR-2 biotarget. 
                            Scientific Reports
                            , 15
                            (1)
                            .
                            https://doi.org/10.1038/s41598-025-29322-6
                        

Identifiers

DOI: 10.1038/s41598-025-29322-6